DDX8, also known as DEAD-box helicase 8, is a member of the DEAD-box protein family, which is characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD). These proteins are putative RNA helicases which are implicated in a number of cellular processes involving the alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. The specific biological role of DDX8 remains an area of active study, but like other members of its family, it is presumed to play a role in RNA metabolism and modification, engaging in the dynamic regulation of RNA structures. DEAD-box proteins are essential for the proper function of RNA-dependent processes and are often involved in the response to cellular stress, participating in the adaptation of the translation machinery to rapidly changing cellular environments.
Research into the regulation of DDX8 expression has suggested that various small molecules and chemical compounds can potentially serve as activators, influencing the levels of this protein within the cell. For instance, retinoic acid, a metabolite of vitamin A, can bind to nuclear receptors and may initiate the transcription of genes including DDX8. Similarly, compounds like Trichostatin A and Sodium butyrate are known histone deacetylase inhibitors and could thereby facilitate a more open chromatin state, making the DDX8 gene more accessible for transcriptional machinery. Forskolin, through its effect on cAMP levels, could also stimulate a signaling cascade that results in the increased expression of DDX8 by activating protein kinase A. Compounds such as β-Estradiol, through its interaction with estrogen receptors, could potentially stimulate the transcription of estrogen-responsive genes, which might include DDX8. It is important to note that while these compounds have been known to act as general regulators of gene expression, the direct relationship with DDX8 expression is a subject of ongoing research, and their specific influences on DDX8 expression would require further empirical study to establish clear mechanistic pathways.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can initiate transcription by binding to retinoic acid receptors, which may lead to the upsurge in DDX8 synthesis by promoting the transcription of its gene. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could promote the unwinding of DNA around histones, enhancing the accessibility of the DDX8 gene for transcription machinery, thereby potentiating its expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methylation, 5-Azacytidine could provoke the activation of previously silenced genes, potentially including DDX8, resulting in heightened expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may trigger the synthesis of DDX8 by catalyzing an increase in cAMP, which activates protein kinase A, subsequently stimulating transcription factors that elevate DDX8 gene transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate has the capacity to escalate transcriptional activity by interacting with specific signaling pathways, which could lead to a surge in DDX8 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate could augment the expression of DDX8 by inhibiting histone deacetylation, creating a more transcriptionally active chromatin state for the DDX8 gene. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might stimulate the synthesis of DDX8 through the activation of sirtuin proteins that promote transcription of longevity-related genes, possibly including DDX8. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may enhance transcription factor binding to the promoter region of DDX8, thereby heightening its gene transcription and subsequent protein synthesis. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is known to elevate gene expression by interacting with glucocorticoid response elements; it could thus promote the transcription of the DDX8 gene. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride may catalyze the expression of DDX8 by inhibiting GSK-3, which may upregulate transcription factors that are pivotal for DDX8 expression. | ||||||